(19)
(11) EP 0 655 924 A1

(12)

(43) Date of publication:
07.06.1995 Bulletin 1995/23

(21) Application number: 93906955.0

(22) Date of filing: 21.10.1992
(51) International Patent Classification (IPC): 
C12N 15/ 02( . )
A61P 35/ 00( . )
C07K 16/ 32( . )
A61K 38/ 00( . )
A61K 39/ 395( . )
C07K 16/ 30( . )
C12P 21/ 08( . )
(86) International application number:
PCT/US1992/008545
(87) International publication number:
WO 1994/000136 (06.01.1994 Gazette 1994/02)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL SE

(30) Priority: 30.06.1992 US 19920906555

(71) Applicant: ONCOLOGIX, INC.
Gaithersburg, MD 20878 (US)

(72) Inventors:
  • KASPRZYK, Philip, G.
    Washington, DC 20010 (US)
  • KING, Charles, R.
    Washington, DC 20010 (US)

(74) Representative: Weisert, Annekäte, Dipl.-Ing. Dr.-Ing. 
Patentanwälte Kraus Weisert & Partner Thomas-Wimmer-Ring 15
D-80539 München
D-80539 München (DE)

   


(54) A COMBINATION OF ANTI-erbB-2 MONOCLONAL ANTIBODIES AND METHOD OF USING